Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Dr. Brentjens on Challenges of CAR-Modified T Cells

March 31st 2014

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses the challenges associated with CAR-modified T cells.

Younger Patients With ALL Could Bypass a Transplant

March 31st 2014

The role of allogeneic transplant in the treatment of adult patients with acute lymphoblastic leukemia (ALL) is evolving as a result of new studies providing evidence of the efficacy of an improved chemotherapy regimen

Dr. Litzow on Transplants in Patients with ALL

March 27th 2014

Mark R. Litzow, MD, chair, ECOG-ACRIN Leukemia Committee, professor of medicine, Division of Hematology, Mayo Clinic, discusses the role of transplant in patients with acute lymphoblastic leukemia

Dr. Goy on Future Agents Against Lymphoma

March 26th 2014

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses emerging agents in lymphoma.

Obinutuzumab Gains Role in CLL Guidelines

March 25th 2014

Amid advances in targeted therapies for patients with chronic lymphocytic leukemia (CLL), researchers also have been making strides in the realm of chemoimmunotherapy regimens for the disease.

Dr. Faderl Gives an Overview of Novel Therapies for AML

March 25th 2014

Stefan Faderl, MD, chief, Leukemia Division, John Theurer Cancer Center, gives an overview of novel therapies for the treatment of patients with acute myeloid leukemia (AML).

Gilead Sciences Moves Ahead on Idelalisib Filings

March 24th 2014

Founded in 1987, Gilead Sciences made a name for itself in 1996, when it launched Vistide, a treatment for cytomegalovirus retinitis in patients with AIDS.

Dr. Ferrajoli on Individualized Treatment of CLL

March 21st 2014

Alessandra Ferrajoli, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses individualizing the treatment of chronic lymphocytic leukemia (CLL).

Dr. Anas Younes Discusses IPI-145 and ABT-199

March 19th 2014

Anas Younes, MD, chief, Lymphoma Service, Memorial Sloan Kettering Cancer Center, discusses the clinical value of IPI-145 and ABT-199 as treatment options for lymphoid malignancies.

Dr. Wierda on the Treatment of Elderly CLL Patients

March 12th 2014

William G. Wierda, MD, PhD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment recommendations for patients with CLL.

Lymphoid Malignancy Treatment Considerations

March 11th 2014

Novel Agents and Chemotherapy Regimens in PTCL

March 11th 2014

Novel Treatment Strategies for PTCL

March 11th 2014

Exploratory Therapies for Hodgkin Lymphoma

March 11th 2014

Treatment Selection for Peripheral T-cell Lymphoma

March 11th 2014

Novel Agents and Combinations in Hodgkin Lymphoma

March 11th 2014

Pretransplant Brentuximab Vedotin in Hodgkin Lymphoma

March 11th 2014

Frontline Treatment of Hodgkin Lymphoma

March 11th 2014

Role of Radiation Therapy in Hodgkin Lymphoma

March 11th 2014

Novel ADCs in Development for Lymphoid Malignancies

March 11th 2014